About Almondz Global Securities Ltd
Almondz Global Securities in the business of providing professional advisory and consultancy services in the areas of equity and debt capital markets, private equity and M&A, infrastructure advisory, equity broking and wealth management, debt portfolio management services and distribution, providing commodity trading platform at MCX and NCDEX to retail and corporate sectors, providing technical and consultancy services in the areas of management, engineering, industrial, technical and financial for infrastructure sectors, receiving brokerage and commission by providing services in the above mentioned sectors, real estate services, health care activities, providing diagnostic and treatment services across all spectrums of eye disorders.
Founded
1994
CEO
Satish Chandra Sinha
Employees
180
HQ
Delhi, India
Finished Products
1fee income
₹51.77Cr2Profit on sale of Investment
₹6.45Cr3Other Operating Income
₹4.81Cr4Interest
₹1.67Cr5Interest on Delayed payment
₹1.34Cr6Sale of Bonds/Securities
₹1.15Cr7Net gain on fair value changes
₹0.65Cr1–7 of 11
Raw Materials
No raw materials reported
This company hasn’t disclosed any raw materials breakdown.
About Almondz Global Securities Ltd
Almondz Global Securities in the business of providing professional advisory and consultancy services in the areas of equity and debt capital markets, private equity and M&A, infrastructure advisory, equity broking and wealth management, debt portfolio management services and distribution, providing commodity trading platform at MCX and NCDEX to retail and corporate sectors, providing technical and consultancy services in the areas of management, engineering, industrial, technical and financial for infrastructure sectors, receiving brokerage and commission by providing services in the above mentioned sectors, real estate services, health care activities, providing diagnostic and treatment services across all spectrums of eye disorders.
Founded:1994
CEO:Satish Chandra Sinha
Employees:180
HQ:Delhi, India
Finished Products
1fee income
₹51.77Cr2Profit on sale of Investment
₹6.45Cr3Other Operating Income
₹4.81Cr4Interest
₹1.67Cr5Interest on Delayed payment
₹1.34Cr6Sale of Bonds/Securities
₹1.15Cr7Net gain on fair value changes
₹0.65Cr1–7 of 11
Raw Materials
No raw materials reported
This company hasn’t disclosed any raw materials breakdown.
Price Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹22
52W Low
₹11
Volume286.31K
Avg VolumeN/A
Beta1.46
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
8.89x
Valuation
P/B Ratio
1.13x
Valuation
EPS
₹1.96
Valuation
Dividend Yield
0.00%
Valuation
ROE
10.67%
Profitability
ROCE
11.57%
Profitability
Revenue by Segment
Contribution & growth by business line
Corporate finance & advisory fee
+60.4%85.1%
₹127.21 Cr
Wealth/Broking activities
+8.2%13.6%
₹20.29 Cr
Debt & Equity Market Operations
-88.3%1.0%
₹1.53 Cr
Others
-45.1%0.3%
₹0.45 Cr
Healthcare services
-94.4%0.1%
₹0.08 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.18x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
25.2%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.